Bothell, WA, United States of America

Zachary Crook

This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Fred Hutchinson Cancer Center. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Zachary Crook in Cancer Research

Introduction

Zachary Crook is an innovative inventor based in Bothell, WA (US). He has made significant contributions to the field of cancer research through his patented work. His research focuses on disrupting TEAD interactions, which play a crucial role in the HIPPO pathway, a key regulator of cell growth.

Latest Patents

Zachary Crook holds a patent for "Peptide compositions and methods of use thereof for disrupting TEAD interactions." This patent describes peptides and their variants capable of interacting with TEAD, thereby disrupting the HIPPO pathway. The invention also includes pharmaceutical compositions and methods for designing and manufacturing these peptides to treat cancer and other diseases associated with dysregulated HIPPO pathways or uncontrolled cell growth.

Career Highlights

Zachary Crook is affiliated with the Fred Hutchinson Cancer Center, where he conducts his research. His work is pivotal in developing new therapeutic strategies for cancer treatment. He has demonstrated a commitment to advancing scientific knowledge and improving patient outcomes through innovative research.

Collaborations

Zachary collaborates with esteemed colleagues, including James M. Olson and Philip Bradley. These collaborations enhance the research efforts at the Fred Hutchinson Cancer Center and contribute to the development of effective cancer therapies.

Conclusion

Zachary Crook's innovative work in peptide compositions and TEAD interactions represents a significant advancement in cancer research. His contributions have the potential to lead to new treatments for diseases associated with the HIPPO pathway.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…